Latest Thiomersal controversy Stories
In the news release, The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies' Failure to Provide Adequate Safety Research, issued 24-Feb-2010 by Coalition for Vaccine Safety over PR Newswire, we are advised by the organization that the tenth paragraph, first sentence, should read "The letter can be found at http://www.coalitionforvaccinesafety.org/letters" rather than "http://www.coaltionforvaccinesafety.org" as originally issued inadvertently.
CASE NOT CLOSED ON GOVERNMENT VACCINE SAFETY CLAIMS WASHINGTON, Feb.
RYE, N.Y., Feb. 22 /PRNewswire/ -- Curemark LLC, (www.curemark.com), a drug research and development company focused on the treatment of neurological diseases, announced that its CM-AT autism treatment, now in Phase III clinical trials, has been designated as a Fast Track drug by the U.S.
Autism Speaks is encouraged by new language recommending funding of vaccine research.
The Autism Research Institute calls for further investigations into the use of chelation therapy for individuals with autism SAN DIEGO, Nov.
ROCHESTER, N.Y., Oct. 30 /PRNewswire-USNewswire/ -- The injectable, multi-dose H1N1 vaccine contains the mercury-based preservative thimerosol to reduce risks of bacterial contamination.
Same preservative used in H1N1 Shots Puts Children at Risk for Brainstem Injury NIXA, Mo., Oct.
NIXA, Mo., Feb.
Government Conceded One Year Ago that Vaccines Caused Autism; Today's Ruling Demonstrates Backpedaling, Further Undermines Vaccine Safety NIXA, Mo., Feb.
SafeMinds Withdraws Support for Autism Research Strategic Plan, Asks Daschle to Investigate. WASHINGTON, Jan.